Mentari Therapeutics(DE:MWG0)
€14.300.00 (0.00%)
DE:MWG0
Mentari Therapeutics stock forecast
€14.30
At close:0.00 (0.00%)
Mentari Therapeutics (MWG0) Stock Forecast & Price Target
1 Followers
MWG0 Analyst Ratings
Strong Buy
4Buy0Hold0Sell
Based on 4 analysts giving stock ratings to Mentari Therapeutics in the past 3 months
MWG0 Stock 12 Month Forecast
Average Price Target
€30.44▲(112.88% Upside)Based on 4 Wall Street analysts offering 12 month price targets for Mentari Therapeutics in the last 3 months. The average price target is EUR 30.44 with a high forecast of EUR 37.60 and a low forecast of EUR 26.86. The average price target represents a 112.88% change from the last price of EUR 14.30.
Past 12 Months12 Month ForecastJan2026Oct2026
High€37.60
Average€30.44
Low€26.86
Highest Price TargetHighest€37.60Average Price Target€30.44Lowest Price TargetLowest€26.86
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Tyler Van Buren | TD Cowen | ― | buy | ― | Initiated | 11/11/26 | ||
| Paul Matteis | Stifel Nicolaus | €26.86 | buy | 87.84%Upside | Initiated | 11/10/26 | ||
| Andrew Tsai | Jefferies | €26.86 | buy | 87.84%Upside | Initiated | 11/10/26 | ||
 Unknown AnalystNot Ranked | Guggenheim | €37.60 | buy | 162.97%Upside | Initiated | 11/09/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Tyler Van BurenTD Cowen | BuyInitiated | 11/11/26 | ― | ||
| Paul MatteisStifel Nicolaus | BuyInitiated€26.86 | 11/10/26 | 87.84%Upside | ||
| Andrew TsaiJefferies | BuyInitiated€26.86 | 11/10/26 | 87.84%Upside | ||
| Unknown AnalystGuggenheimNot Ranked | BuyInitiated€37.60 | 11/09/26 | 162.97%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MWG0 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 3 |
| Buy | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 4 |
In the current month, MWG0 has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MWG0 average Analyst price target in the past 3 months is 30.44.
MWG0 Financial Forecast
Consensus€-0.38
MWG0 Earnings Forecast
Next quarter’s earnings estimate for MWG0 is -EUR 0.38 with a range of ― to ―. The previous quarter’s EPS was -EUR 0.38. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
Consensus€0.00
MWG0 Sales Forecast
Next quarter’s sales forecast for MWG0 is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
MWG0 Stock Forecast FAQ
What is DE:MWG0’s average 12-month price target, according to analysts?
Based on analyst ratings, Mentari Therapeutics’s 12-month average price target is €30.44.
What is DE:MWG0’s upside potential, based on the analysts’ average price target?
Mentari Therapeutics has 112.88% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Mentari Therapeutics a Buy, Sell or Hold?
Mentari Therapeutics has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Mentari Therapeutics’s share price target?
The average share price target for Mentari Therapeutics is €30.44. This is based on 4 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €37.60, and the lowest forecast is €26.86. The average share price target represents a 112.88% increase from the current price of €14.3.
What do analysts say about Mentari Therapeutics?
Mentari Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of Mentari Therapeutics?
To buy shares of DE:MWG0, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
